Back to Search
Start Over
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
- Source :
- Plus Company Updates. May 24, 2024
- Publication Year :
- 2024
-
Abstract
- CAMBRIDGE: Nona Biosciences has issued the following news release: Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from target validation [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.795126355